Control Risks is a specialist global risk consultancy that helps organisations succeed in a volatile world. Through insight, intelligence and technology, we help you seize opportunities while remaining secure, compliant and resilient. When crises and complex issues arise, we help you recover.
All content for Control Risks is the property of Control Risks and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Control Risks is a specialist global risk consultancy that helps organisations succeed in a volatile world. Through insight, intelligence and technology, we help you seize opportunities while remaining secure, compliant and resilient. When crises and complex issues arise, we help you recover.
Life Science Series: Risks for multinational pharmaceuticals in India
Control Risks
13 minutes 25 seconds
1 year ago
Life Science Series: Risks for multinational pharmaceuticals in India
India is an important market for many multinational pharmaceutical, biotech or medical device companies. But it is also a challenging one.
Join Martina Rozumberkova for a conversation with Sushmit Bhattacharya about challenges facing multinational pharmaceutical companies operating in India, from important regulatory changes, including the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, to emerging fraud schemes, including fraud in the Government e-Marketplace (GeM) and retailer incentive schemes.
Control Risks
Control Risks is a specialist global risk consultancy that helps organisations succeed in a volatile world. Through insight, intelligence and technology, we help you seize opportunities while remaining secure, compliant and resilient. When crises and complex issues arise, we help you recover.
